We are live on ! Find out more
AG

Algert Global Portfolio holdings

AUM $6.65B
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+13.2%
1 Year Est. Return
+53.68%
3 Year Est. Return
+140.8%
5 Year Est. Return
+204.57%
10 Year Est. Return
+1,528.09%
AUM
$4.77B
AUM Growth
+$731M
Cap. Flow
+$361M
Cap. Flow %
7.56%
Top 10 Hldgs %
5.9%
Holding
1,379
New
219
Increased
460
Reduced
380
Closed
212

Top Sells

Rank Stock Value
1
GMED icon
Globus Medical
GMED
+$11.3M
2
HURN icon
Huron Consulting
HURN
+$10.8M
3
FHI icon
Federated Hermes
FHI
+$10.5M
4
OUT icon
Outfront Media
OUT
+$10.4M
5
GFF icon
Griffon
GFF
+$10.3M

Sector Composition

Rank Sector Weight
1 Technology 16.45%
2 Industrials 15.7%
3 Financials 15.48%
4 Consumer Discretionary 12.41%
5 Healthcare 12.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLSK icon
551
CleanSpark
CLSK
$3.93B
$2.61M 0.05%
236,993
+15,600
+7% +$139K
MAC icon
552
Macerich
MAC
$7.19B
$2.58M 0.05%
159,724
KLIC icon
553
Kulicke & Soffa
KLIC
$5.53B
$2.58M 0.05%
74,490
+67,280
+933% +$2.19M
NVCR icon
554
NovoCure
NVCR
$1.8B
$2.57M 0.05%
144,623
+46,872
+48% +$817K
IOSP icon
555
Innospec
IOSP
$2.1B
$2.57M 0.05%
30,548
+1,690
+6% +$148K
SRPT icon
556
Sarepta Therapeutics
SRPT
$1.67B
$2.56M 0.05%
149,910
+73,241
+96% +$3.12M
RNG icon
557
RingCentral
RNG
$3.16B
$2.56M 0.05%
90,219
-33,230
-27% -$857K
PNTG icon
558
Pennant Group
PNTG
$1.41B
$2.56M 0.05%
85,630
-50,811
-37% -$1.39M
RVMD icon
559
Revolution Medicines
RVMD
$38.9B
$2.54M 0.05%
68,983
+22,010
+47% +$846K
SEDG icon
560
SolarEdge
SEDG
$2.91B
$2.53M 0.05%
124,176
+71,706
+137% +$1.19M
HALO icon
561
Halozyme
HALO
$9.23B
$2.53M 0.05%
48,670
+40,690
+510% +$2.32M
MRNA icon
562
Moderna
MRNA
$23B
$2.53M 0.05%
+91,710
New +$2.42M
OMF icon
563
OneMain Financial
OMF
$6.91B
$2.53M 0.05%
44,365
SNCY
564
DELISTED
Sun Country Airlines
SNCY
$2.52M 0.05%
214,551
-43,840
-17% -$482K
VTR icon
565
Ventas
VTR
$47.2B
$2.51M 0.05%
39,804
-7,602
-16% -$496K
MAX icon
566
MediaAlpha
MAX
$720M
$2.5M 0.05%
228,778
+3,478
+2% +$33.6K
PAHC icon
567
Phibro Animal Health
PAHC
$1.37B
$2.5M 0.05%
97,722
+110
+0.1% +$2.4K
PDM
568
Piedmont Realty Trust
PDM
$1.2B
$2.47M 0.05%
339,180
+320,520
+1,718% +$2.21M
TGTX icon
569
TG Therapeutics
TGTX
$8.06B
$2.45M 0.05%
68,081
-8,960
-12% -$334K
AAMI
570
Acadian Asset Management
AAMI
$2.93B
$2.44M 0.05%
69,217
-4,130
-6% -$120K
ENSG icon
571
The Ensign Group
ENSG
$9.88B
$2.44M 0.05%
15,785
-62,930
-80% -$8.83M
AVAH icon
572
Aveanna Healthcare
AVAH
$2.05B
$2.43M 0.05%
464,701
+343,956
+285% +$1.75M
MOG.A icon
573
Moog Inc Class A
MOG.A
$12.8B
$2.42M 0.05%
13,360
-2,570
-16% -$451K
REZI icon
574
Resideo Technologies
REZI
$5.16B
$2.4M 0.05%
108,950
+39,290
+56% +$750K
SDGR icon
575
Schrodinger
SDGR
$1.12B
$2.4M 0.05%
119,376
+27,486
+30% +$628K

Similar funds

Algert Global's Q2 2025 Portfolio in Review

As of Q2 2025, Algert Global held 1,379 positions worth $4.77B, up 18% from $4.04B the previous quarter. Its ten largest holdings account for 5.9% of the portfolio.

Algert Global deployed $361M of net new capital in Q2 2025, opening 219 new positions and adding to 460 existing holdings. Its largest new stake was Millrose Properties Inc: 553,296 shares worth $15.8M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Huron Consulting, an estimated $10.8M trimmed.

  • Algert Global's largest Q2 2025 buy was Millrose Properties Inc: 553,296 shares worth $15.8M.
  • Algert Global added most to Albemarle in Q2 2025, an estimated $16.7M increase.
  • Algert Global's biggest Q2 2025 reduction was Huron Consulting, cutting an estimated $10.8M.
  • Algert Global fully exited Globus Medical in Q2 2025, selling an estimated $11.3M.
  • Algert Global's ten largest holdings make up 5.9% of its $4.77B portfolio in Q2 2025.
  • Algert Global opened 219 new positions and closed 212 in Q2 2025.
  • Algert Global's portfolio value rose 18% quarter-over-quarter to $4.77B.

Based on Algert Global's 13F filing for Q2 2025, filed 14 Aug 2025.